Work

Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study

Year: 2007

Type: article

Study design: Clinical Trial

Source: The Lancet Oncology

DOI: 10.1016/s1470-2045(07)70285-1

Authors: Olivier Rixe, Ronald M Bukowski, M Dror Michaelson, George Wilding, Gary R Hudes, Oliver Bolte, Robert J Motzer, Paul Bycott, Katherine F Liau, James Freddo, Peter C Trask, Sinil Kim, Brian I Rini

Institutions: Université Paris Cité, Sorbonne Université, Pitié-Salpêtrière Hospital, Cleveland Clinic, Massachusetts General Hospital, University of Wisconsin–Madison, Fox Chase Cancer Center, Medizinische Hochschule Hannover, Memorial Sloan Kettering Cancer Center, Pfizer (United States)

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2123769946

FWCI: 32.79

Cites: 19

Cited by: 435

Related to: 10